Purpose of review
For the more than 636,000 adults with end-stage renal disease (ESRD) in the
U.S., kidney transplantation is the preferred treatment compared to dialysis. Living
donor kidney transplantation (LDKT) comprised 31% of kidney transplantations in
2015, an 8% decrease since 2004. We aimed to summarize the current literature on
decision aids that could be used to improve LDKT rates.
Recent findings
Decision aids are evidence-based tools designed to help patients and their
families make difficult treatment decisions. LDKT decision aids can help ESRD patients,
patients’ family and friends, and healthcare providers engage in treatment
decisions and thereby overcome multifactorial LDKT barriers.
Summary
We identified 12 LDKT decision aids designed to provide information about LDKT,
and/or to help ESRD patients identify potential living donors, and/or to help healthcare
providers make decisions about treatment for ESRD or living donation. Of these, 4 were
shown to be effective in increasing LDKT, donor inquiries, LDKT knowledge, and
willingness to discuss LDKT. Although each LDKT decision aid has limitations, adherence
to decision aid development guidelines may improve decision aid utilization and access
to LDKT.